Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
July 22, 2022
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
Sean Patrick Bliven, Lauren Shea, Susan Bal, et al.
JAMA Network Open
|
December 3, 2019
Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
Lindsey E Roeker, Maryam Sarraf Yazdy, Joanna Rhodes, et al.
Ejhaem
|
May 19, 2023
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, et al.
Plos One
|
March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
Surbhi Sidana, Mayur Narkhede, Paul Elson, et al.
Frontiers in Oncology
|
August 13, 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
Mayur Narkhede, Sarah Tomassetti, Madiha Iqbal, et al.
Journal of Medical Economics
|
December 27, 2025
A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
George Dranitsaris, Aaron Peevyhouse, Heather Neuhalfen, et al.
American Journal of Hematology
|
April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomes
Mayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
American Journal of Hematology
|
December 1, 2023
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse
Matthew R Wilson, Amy A Kirkwood, Nicole Wong Doo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2023
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, et al.
Plos Medicine
|
June 29, 2023
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Clinical Lymphoma, Myeloma & Leukemia
|
July 22, 2022
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
Sean Patrick Bliven, Lauren Shea, Susan Bal, et al.
JAMA Network Open
|
December 3, 2019
Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
Lindsey E Roeker, Maryam Sarraf Yazdy, Joanna Rhodes, et al.
Ejhaem
|
May 19, 2023
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, et al.
Plos One
|
March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
Surbhi Sidana, Mayur Narkhede, Paul Elson, et al.
Frontiers in Oncology
|
August 13, 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
Mayur Narkhede, Sarah Tomassetti, Madiha Iqbal, et al.
Journal of Medical Economics
|
December 27, 2025
A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
George Dranitsaris, Aaron Peevyhouse, Heather Neuhalfen, et al.
American Journal of Hematology
|
April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomes
Mayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
American Journal of Hematology
|
December 1, 2023
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse
Matthew R Wilson, Amy A Kirkwood, Nicole Wong Doo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2023
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, et al.
Plos Medicine
|
June 29, 2023
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, et al.
Page
of 3